Efficacy of oral vancomycin in primary prevention of Clostridium Difficile infection in elderly patients treated with systemic antibiotic therapy

被引:12
作者
Papic, Neven [1 ]
Maric, Lorna Stemberger [1 ,2 ]
Vince, Adriana [1 ,3 ]
机构
[1] Univ Hosp Infect Dis, Zagreb, Croatia
[2] Univ Zagreb, Sch Dent Med, Zagreb, Croatia
[3] Univ Zagreb, Sch Med, Zagreb, Croatia
关键词
RESISTANT ENTEROCOCCI; METRONIDAZOLE; EPIDEMIOLOGY; DISEASE; ADULTS;
D O I
10.1080/23744235.2018.1425551
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:483 / 486
页数:4
相关论文
共 50 条
[41]   Efficacy of fidaxomicin versus vancomycin in the treatment of Clostridium difficile infection: A systematic meta-analysis [J].
Zhao, Zihan ;
Wu, Yarui ;
Geng, Xuhua ;
Yuan, Congrui ;
Fu, Yi ;
Yang, Guibin .
MEDICINE, 2024, 103 (32) :e39213
[42]   Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population [J].
Morrisette, Taylor ;
Van Matre, Amanda G. ;
Miller, Matthew A. ;
Mueller, Scott W. ;
Bajrovic, Valida ;
Abidi, Maheen Z. ;
Benamu, Esther ;
Kaiser, Jeffrey N. ;
Barber, Gerard R. ;
Chase, Stephanie ;
Tobin, Jennifer ;
Fish, Douglas N. ;
Gutman, Jonathan A. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (10) :2091-2097
[43]   Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection [J].
Crow, Jessica R. ;
Davis, Stephanie L. ;
Chaykosky, Darlene M. ;
Smith, Tiffeny T. ;
Smith, Janessa M. .
PHARMACOTHERAPY, 2015, 35 (11) :1016-1025
[44]   Cost-Effectiveness Analysis Evaluating Fidaxomicin versus Oral Vancomycin for the Treatment of Clostridium difficile Infection in the United States [J].
Stranges, Paul M. ;
Hutton, David W. ;
Collins, Curtis D. .
VALUE IN HEALTH, 2013, 16 (02) :297-304
[45]   Oral Teicoplanin as an Alternative First-Line Regimen in Clostridium difficile Infection in Elderly Patients: A Case Series [J].
Benjamin Davido ;
Céline Leplay ;
Frédérique Bouchand ;
Aurélien Dinh ;
Maryvonne Villart ;
Jean-Laurent Le Quintrec ;
Laurent Teillet ;
Jérôme Salomon ;
Hugues Michelon .
Clinical Drug Investigation, 2017, 37 :699-703
[46]   Effect of age, dose and antibiotic therapy on the development of Clostridium difficile infection in neonatal piglets [J].
Arruda, Paulo H. E. ;
Madson, Darin M. ;
Ramirez, Alejandro ;
Rowe, Eric ;
Lizer, Joshua T. ;
Songer, J. Glenn .
ANAEROBE, 2013, 22 :104-110
[47]   Risk factors, preemptive therapy, and antiperistaltic agents for Clostridium difficile infection in cancer patients [J].
Krishna, S. G. ;
Zhao, W. ;
Apewokin, S. K. ;
Krishna, K. ;
Chepyala, P. ;
Anaissie, E. J. .
TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (05) :493-501
[48]   Rifaximin Therapy for Patients With Metronidazole-Unresponsive Clostridium difficile Infection [J].
Waqas, Muhammad ;
Mohib, Khadija ;
Saleem, Aniqa ;
Lnu, Mahak ;
Arjumand, Sabeen ;
Khalil, Hafiz Habib Ur Rehman ;
Nosheen, Rukhshanda ;
Abbas, Sharmeen ;
Maqsood, Kanza M. ;
Abbas, Kiran .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
[49]   Clostridium Difficile Infection The effects of acid suppression therapy in patients with cancer [J].
Lan, Hannah .
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2019, 23 (02) :165-171
[50]   Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients [J].
Ganetsky, Alex ;
Han, Jennifer H. ;
Hughes, Mitchell E. ;
Babushok, Daria V. ;
Frey, Noelle V. ;
Gill, Saar I. ;
Hexner, Elizabeth O. ;
Loren, Alison W. ;
Luger, Selina M. ;
Mangan, James K. ;
Martin, Mary Ellen ;
Smith, Jacqueline ;
Freyer, Craig W. ;
Gilmar, Cheryl ;
Schuster, Mindy ;
Stadtmauer, Edward A. ;
Porter, David L. .
CLINICAL INFECTIOUS DISEASES, 2019, 68 (12) :2003-2009